US Stock MarketDetailed Quotes

IQV IQVIA Holdings

Watchlist

228.090
+0.920+0.40%

Close Apr 19 16:00 ET

228.090
0.0000.00%

Post 16:15 ET

41.52BMarket Cap31.29P/E (TTM)

IQVIA Holdings Stock Forum

Moomoo AI

Mar 7 05:08

Insiders' substantial share sale, especially by W. Staub and Constantinos Panagos, may worry shareholders. The lack of insider purchases over the past year could be a negative sign. Yet, high insider ownership might indicate well-aligned management incentives with shareholders.

Trade Alert: President of Research & Development Solutions Of IQVIA Holdings W. Staub Has Sold Stock

Bisco

Feb 14 07:10

$IQVIA Holdings(IQV.US)$ Aced the numbers again in a very competitive market

Moomoo AI

Feb 6 08:30

The market's opinion of the business has improved over the past five years, likely due to consistent earnings growth. Despite recent sell-offs, if fundamentals suggest sustainable long-term growth, this could be a worthwhile opportunity.

Those Who Invested in IQVIA Holdings (NYSE:IQV) Five Years Ago Are up 60%

Moomoo AI

Jan 7 06:29

IQVIA Holdings is currently undervalued and has a bright future. Its growth hasn't been fully factored into the share price. It may be a great time to increase holdings or enter the stock.

At US$221, Is It Time To Put IQVIA Holdings Inc. (NYSE:IQV) On Your Watch List?

Moomoo AI

Dec 7, 2023 11:46

Insiders selling shares, even below current price, hint they may deem shares not cheap. Coupled with no insider buying, this may serve as a warning to potential investors. High insider ownership, but recent sale history of IQVIA Holdings insiders could raise concern.

IQVIA Holdings Insiders Sell US$6.6m Of Stock, Possibly Signalling Caution

Moomoo AI

Oct 17, 2023 02:29

Bio-Rad Laboratories is likely to maintain an 80% market share in digital PCR products due to extensive offering and embracing continuous investment. Bio-Techne's extensive product offerings and the growth of its analytical instruments business are likely to drive its growth. For IQVIA, sales growth is primarily expected from managing its existing backlog.

Bio-Rad, IQVIA, Bio-Techne Among Top Picks at Credit Suisse

Moomoo Breakfast US

Feb 5, 2023 19:53

ColumnsWhat to Expect in the Week Ahead (Powell Speaks; DIS, PYPL and UBER Earnings)

Fourth-quarter earnings season continues this week, with close to 90 $S&P 500 Index(.SPX.US)$ companies scheduled to report. So far, earnings are down about 3% from the same period a year ago, per Refinitiv.
$Simon Property(SPG.US)$, $Take-Two Interactive Software(TTWO.US)$, and $Tyson Foods(TSN.US)$ report on Monday, followed by $BP PLC(BP.US)$, $DuPont(DD.US)$, and $Royal Caribbean(RCL.US)$.
$Disney(DIS.US)$, $CVS Health(CVS.US)$, and ...

Analysts Notebook

Nov 17, 2022 06:57

ColumnsUS Top Rating Updates on 11/17: TGT, EL, ICE, IQV and More

Target Upgraded to Overweight From Neutral at Piper Sandler
Piper Sandler analyst Edward Yruma upgraded $Target(TGT.US)$ to Overweight from Neutral with a price target of $200, up from $190. The company has had a difficult 2022, but we are approaching "trough" EBIT margins and the stock's valuation now "looks compelling," Yruma tells investors in a research note.
Canaccord Starts Estee Lauder With Hold, Sees Estimate Risk
Canaccord analys...

Mooers Radar

Oct 26, 2022 04:46

ColumnsUS Top Gap Ups and Downs on 10/25: LOGI, UBS, RBLX, CVS and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $Medpace(MEDP.US)$ - up 25.01%
2. $Logitech International(LOGI.US)$ - up 8.07%
3. $UBS Group(UBS.US)$ - up 5.36%
4. $SAP SE(SAP.US)$ - up 5.30%
5. $Charles River(CRL.US)$ - up 4.30%
6. $IQVIA Holdings(IQV.US)$ - up 3.77%
7. $U-Haul(UHAL.US)$ - up 2.80%
8. $Roblox(RBLX.US)$...